[{"Assets_0_Q1_USD":"14373698000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-112.57","EarningsPerShareDiluted_1_Q1_USD":"-112.57","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"46315000.0","NetIncomeLoss_1_Q1_USD":"-3369600000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q1_USD":"700100000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q1_USD":"10182916000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"29933000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"29933000.0","filed":"20220429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"BIO-RAD LABORATORIES, INC.","period":"20220331","qtrs":"1","uom":"shares"}]